This Flurbiprofen 100 mg/g and Lidocaine 50 mg/g topical cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is formulated to provide localized treatment and absorption of active ingredients, offering relief from pain and inflammation associated with conditions such as arthritis, tendonitis, and localized musculoskeletal pain. The combination of Flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID), and Lidocaine, a local anesthetic, works synergistically to reduce inflammation and numb the affected area.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This formulation is a topical cream containing Flurbiprofen 100 mg/g and Lidocaine 50 mg/g, designed for application on the skin using a convenient pump mechanism. The semisolid preparation allows for controlled and localized delivery of active ingredients directly to the affected area. Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce inflammation and pain by inhibiting prostaglandin synthesis. Lidocaine is a local anesthetic that provides rapid pain relief by blocking nerve signals in the skin.
When combined in a topical cream, Flurbiprofen and Lidocaine work synergistically to alleviate pain and reduce inflammation associated with various musculoskeletal conditions. This formulation is particularly useful for managing localized pain due to arthritis, tendonitis, bursitis, sprains, strains, and other soft tissue injuries. The targeted application minimizes systemic absorption, potentially reducing the risk of systemic side effects commonly associated with oral NSAIDs.
The pump mechanism ensures accurate dosing and reduces the potential for mess or wastage. To use the cream, apply the prescribed amount to the affected area and gently massage until absorbed. Wash hands thoroughly after application to avoid accidental contact with eyes or mucous membranes.
Prescribers may find this formulation beneficial for patients who cannot tolerate oral NSAIDs or who require additional localized pain control. The combination of an anti-inflammatory agent with a local anesthetic addresses both the underlying inflammation and immediate pain sensations. It is important to assess the patient's overall medication profile to avoid potential interactions and to consider any contraindications such as hypersensitivity to NSAIDs or local anesthetics.
Common side effects may include skin irritation at the application site, such as redness, itching, or rash. Patients should discontinue use and consult their healthcare provider if they experience severe irritation or signs of an allergic reaction. As with all medications, it is important to use this cream exactly as prescribed and to report any concerning symptoms to a healthcare professional promptly.
If you have any questions about this formulation or its use, please reach out to us.
Flurbiprofen 100 mg/g and Lidocaine 50 mg/g topical cream is a compounded formulation designed for localized treatment of pain and inflammation. Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, thereby reducing inflammation and pain. Lidocaine is a local anesthetic that provides pain relief by blocking nerve signals in the body. When combined in a topical cream, these active ingredients offer a synergistic effect for the management of localized pain conditions.
Patients and prescribers should be aware of potential drug interactions when using this topical formulation. Although the systemic absorption of flurbiprofen and lidocaine from topical application is generally lower compared to oral or injectable forms, interactions can still occur, especially with prolonged use or application over large surface areas. It is important to consider the patient's overall medication regimen to avoid adverse effects.
Flurbiprofen, as an NSAID, may interact with other medications that affect bleeding risk, such as anticoagulants (e.g., warfarin), antiplatelet agents (e.g., aspirin, clopidogrel), and other NSAIDs. Concurrent use of these medications can increase the risk of gastrointestinal bleeding and should be monitored closely. Additionally, flurbiprofen may reduce the efficacy of antihypertensive drugs, including ACE inhibitors, angiotensin II receptor blockers, and diuretics, potentially leading to elevated blood pressure.
Lidocaine, when absorbed systemically, can interact with antiarrhythmic drugs, such as amiodarone and mexiletine, potentially leading to additive cardiac effects. Caution is advised when using this topical cream in patients receiving these medications. Furthermore, lidocaine may enhance the effects of other local anesthetics and should be used with caution in patients receiving multiple local anesthetic agents.
Patients with pre-existing conditions such as liver or kidney impairment should use this formulation with caution, as these conditions can affect the metabolism and excretion of both flurbiprofen and lidocaine, potentially leading to increased systemic exposure and risk of toxicity. It is crucial to assess the patient's medical history and current medications to ensure safe use of this topical cream.
If you have any questions or concerns about potential drug interactions or the use of this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
The Flurbiprofen 100 mg/g and Lidocaine 50 mg/g topical cream is a compounded semisolid preparation designed for targeted application on the skin, utilizing a pump mechanism for precise and controlled dosing. This formulation is specifically crafted to deliver the active ingredients directly to the site of pain or inflammation, providing localized treatment and minimizing systemic exposure. The combination of Flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID), and Lidocaine, a local anesthetic, offers a dual-action approach to managing pain and inflammation.
Flurbiprofen works by inhibiting the cyclooxygenase (COX) enzymes, which are responsible for the synthesis of prostaglandins. Prostaglandins are lipid compounds that play a key role in the inflammatory process, contributing to pain, swelling, and redness. By reducing the production of these compounds, Flurbiprofen effectively decreases inflammation and alleviates pain at the site of application. This makes it particularly useful for conditions characterized by localized inflammation, such as arthritis, tendonitis, or musculoskeletal injuries.
Lidocaine, on the other hand, acts as a local anesthetic by blocking sodium channels in the neuronal cell membrane. This action prevents the initiation and conduction of nerve impulses, leading to a temporary loss of sensation in the treated area. By numbing the skin and underlying tissues, Lidocaine provides immediate pain relief, which can be especially beneficial for acute pain episodes or during the initial phase of treatment when inflammation is most pronounced.
The pump mechanism of this topical cream ensures that patients and prescribers can easily control the amount of medication applied, promoting consistent dosing and reducing the risk of over-application. This feature enhances patient compliance and optimizes therapeutic outcomes by ensuring that the active ingredients are delivered in the correct concentration to the affected area.
For prescribers, it provides a customizable treatment option that can be tailored to the specific needs of each patient, allowing for adjustments in dosing or frequency based on the severity of symptoms and individual response to treatment.
If you have any questions about this formulation or its use, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your treatment options.
Flurbiprofen 100 mg/g and Lidocaine 50 mg/g topical cream, dispensed in a semisolid preparation with a pump mechanism, offers a versatile option for localized treatment or absorption of active ingredients through the skin. While primarily used for managing pain and inflammation associated with musculoskeletal conditions, this formulation may have other potential applications that could benefit both patients and prescribers seeking alternative therapeutic options. The combination of flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID), and lidocaine, a local anesthetic, provides a dual-action approach that can be particularly useful in managing localized pain and inflammation.
Beyond its primary indications, this topical cream may be considered for off-label uses in conditions where localized pain relief and anti-inflammatory effects are desired. For instance, it could be beneficial in managing pain associated with minor injuries such as sprains, strains, or contusions, where reducing inflammation and providing immediate pain relief can aid in faster recovery. Additionally, patients with localized neuropathic pain conditions, such as post-herpetic neuralgia or diabetic neuropathy, might find relief from the numbing effect of lidocaine combined with the anti-inflammatory properties of flurbiprofen.
In dermatological settings, this formulation might be explored for its potential to alleviate discomfort from inflammatory skin conditions, such as localized psoriasis or eczema flare-ups, where inflammation and pain are prominent symptoms. Furthermore, it could be used in post-surgical settings to manage localized pain and inflammation, potentially reducing the need for systemic pain medications and their associated side effects. The pump mechanism ensures precise dosing and minimizes wastage, making it a convenient option for patients who require consistent and controlled application.
It is important for prescribers to consider the patient's overall health status, potential drug interactions, and specific needs when contemplating the use of this formulation for off-label purposes. Patients should be advised to apply the cream as directed and report any adverse reactions or lack of efficacy to their healthcare provider. As with any medication, the benefits and risks should be carefully weighed, and usage should be tailored to the individual patient's condition and response to treatment. If you have any questions or need further information about this formulation, please reach out to us at Bayview Pharmacy.
This topical cream is used for localized treatment of pain and inflammation. Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce inflammation and pain, while Lidocaine is a local anesthetic that numbs the area to provide relief from discomfort.
The cream should be applied to clean, dry skin. Dispense the cream using the pump mechanism and gently rub it into the affected area until it is absorbed. Follow your healthcare provider's instructions regarding the amount and frequency of application.
No, you should not apply this cream to broken, irritated, or infected skin. Doing so may increase the risk of side effects and irritation. Consult your healthcare provider for alternative treatments if you have open wounds or skin conditions.
Some common side effects may include mild skin irritation, redness, or itching at the application site. If you experience severe irritation, rash, or any signs of an allergic reaction, discontinue use and contact your healthcare provider immediately.
The pump mechanism is designed for convenient and controlled application. It dispenses a measured amount of cream with each pump, ensuring consistent dosing and minimizing waste. Simply press the pump to release the cream onto your hand or directly onto the affected area.
Before using this cream with other topical medications, consult your healthcare provider. Combining multiple topical treatments may increase the risk of skin irritation or alter the effectiveness of the medications.
Store the cream at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not freeze the cream, as this may affect its consistency and effectiveness.
If you are pregnant or breastfeeding, consult your healthcare provider before using this cream. They will assess the potential risks and benefits to determine if it is appropriate for your situation.
The onset of relief can vary depending on the individual and the severity of the condition being treated. Some users may experience relief within a few hours, while others may require several applications over a few days to notice significant improvement.
This cream is specifically formulated for the treatment of localized pain and inflammation.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)